Amyotrophic Lateral Sclerosis (ALS)
Running Complex Trials for Rare Neurological Disorders
Biorasi has the expertise, methodology, and technology to facilitate successful clinical trials for ALS studies.
Biorasi Understands the Complexities of ALS and Other Rare Diseases
The operational strategy for Amyotrophic Lateral Sclerosis (ALS) trials is markedly more complex than those for traditional pharmaceuticals. The standard responsibilities of maintaining clinical trial protocols, short and long-term schedules and milestones, and project budgets are just a small part of the logistical burden.
Who should you turn to for in-depth knowledge and experience in ALS pathobiology and treatment design? Look no further than Biorasi – a new kind of CRO.
Optimizing ALS Clinical Trials
As your CRO partner, Biorasi is your expert advisor in the ALS study ecosystem. Our experience in ALS trials includes proficiency in:
- Working with patient advocacy groups to remove obstacles to engagement of ALS subjects.
- Deploying a global strategy, including an international recruitment campaign designed to reach potential patients.
- Optimizing on-site and remote treatment for ALS patients through strong communication with clinical teams and digital technology solutions.